US grants Moderna $176 million to develop a bird flu vaccine
The US government gave Moderna $176 million to develop a bird flu vaccine. The funding is intended to support research and development efforts to develop vaccines that can combat bird…
Roche’s Xolair reduces reactions to severe food allergies in study
NEW YORK — Xolair, a 20-year-old asthma drug marketed by Roche and Novartis, significantly reduced allergic reactions in people with multiple severe food allergies in a late-stage study, researchers reported…







